Physician profile
Allison Guyen
NPI 1487622023
$7,372.96
in general payments reported to CMS, 2019-2025
13 companies · $21.81 in 2025
The $21.81 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,833 · 2021: $1,310 · 2022: $103 · 2024: $105 · 2025: $21.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,839.43 | 2019-2021 | |
| Southern Edge Orthopaedics, INC. | $1,200.00 | 2021 | |
| Wright Medical Technology, INC. | $672.80 | 2019 | |
| Treace Medical Concepts, INC. | $271.44 | 2019-2024 | |
| Integra Lifesciences Corporation | $117.85 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $62.41 | 2019 | |
| Foundation Medicine, INC. | $55.75 | 2021 | |
| Smith+Nephew, INC. | $33.71 | 2019-2021 | |
| Grt US Holding, INC. | $32.09 | 2022 | |
| Acorda Therapeutics, INC | $24.30 | 2019 | |
| Kerecis Limited | $24.14 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Djo, LLC | $21.81 | 2025 | Cmf |
| Horizon Therapeutics Plc | $17.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Guyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.